SolventumvsUnitedHealth

SOLV and UNH stock compared: price, dividend, valuation and results, from SEC filings.

SOLV

Solventum Corporation

$86.06

Value $14.9B

-2.92%
SOLV's page

UNH

UnitedHealth Group Incorporated

$389.68

Value $354B

-5.42%
UNH's page

Solventum (SOLV) has a market value of $14.9B and UnitedHealth (UNH) $354B. Over the last year, with dividends, SOLV moved +13.7% and UNH +24.3%. The P/E is 95.7 for SOLV and 22.3 for UNH. Dividend yield: SOLV none, UNH 2.32%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    SOLV$14.9B

    UNH$354B

    UNH is 24 times SOLV

  • Revenue, 12 months

    SOLV$8.2B

    UNH$450B

    UNH is 55 times SOLV

  • Net income, 12 months

    SOLV$156M

    UNH$15.9B

    UNH is 102 times SOLV

  • Operating margin

    SOLV5.6%

    UNH5.3%

    0.3 points apart

  • ROIC

    SOLV4.2%

    UNH11.3%

    7.1 points apart

  • P/E

    SOLV95.7

    UNH22.3

    SOLV is 4.3 times UNH

  • Dividend yield

    SOLV0.0%

    UNH2.3%

    2.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

SOLV+13.7%

UNH+24.3%

100120140DecFebAprJunAugOct
Returns by period
PeriodSOLVWith dividendsUNHWith dividends
1 year since November 14, 2025+13.7%Price +13.7%+24.3%Price +21.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

SOLVSolventumUNHUnitedHealth

Valuation

SOLVUNH
Valuation
Price$86.06$389.68
Market value$14.9B$354B
Enterprise value (EV)$19.8B$399B
P/E95.722.3
P/E, 5-year median–25.0
P/B3.13.4
EV/EBIT43.416.7
Free cash flow yield–6.5%

Results and growth

SOLVUNH
Results and growth
Revenue, 12 months$8.2B$450B
Net income, 12 months$156M$15.9B
Free cash flow, 12 months$0$22.8B
Earnings per share, 12 months$0.88$17.52
Revenue growth, year on year0.9%11.8%
Revenue growth a year, past+0.8%over 3 years+11.7%over 5 years
EPS growth a year, past+4.5%over 3 years-3.8%over 5 years

Margins and returns on capital

SOLVUNH
Margins and returns on capital
Gross margin54.8%88.3%
Operating margin5.6%5.3%
Net margin1.9%3.5%
ROIC4.2%11.3%
ROE3.2%15.5%

Balance sheet

SOLVUNH
Balance sheet
Cash$451M$28.5B
Total debt$5.3B$74.3B
Net debt / EBITDA5.11.6
Interest cover–6.2×

Dividends and buybacks

SOLVUNH
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.6%
Shareholder yield–3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: SOLV or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Solventum or UnitedHealth?

By market value, UnitedHealth ($354B) is about 23.7 times Solventum ($14.9B), at today's prices.

How did SOLV and UNH stock do over the last 1 years?

Since November 14, 2025, SOLV's price moved +13.7% and UNH's +21.1%. With dividends: SOLV +13.7% (+13.7% a year), UNH +24.3% (+24.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, SOLV or UNH?

The dividend yield at today's price is none for Solventum and 2.32% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of SOLV and UNH?

At today's price, the P/E is 95.7 for SOLV and 22.3 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Solventum or UnitedHealth?

Over the last twelve months, the net margin was 1.9% for Solventum and 3.5% for UnitedHealth, and the operating margin 5.6% and 5.3%. Revenue was $8.2B and $450B.

Which is the better investment, Solventum or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.